The Federal Trade Commission secured an important victory to lower healthcare costs and expand access to lifesaving medical devices for Americans by halting Edwards Lifesciences Corp.’s (Edwards) proposed acquisition of JenaValve Technology, Inc (JenaValve). On January 9, 2026, after a six-day trial, the U.S.View Press Release